Submitted by kobrien on 05/06/2022
Gustavo Betini, a PhD student in the school of Public Health Science at the University of Waterloo, has spent the past year immersed in studying the mental health effects of COVID-19. His research has shown that, even though fear of contracting the virus is waning, almost a quarter of Canadians continue to report having high anxiety and depression related to the pandemic.
Submitted by sfisher on 04/27/2022
Structural Genomics Consortium (SGC), the Canadian-led consortium of pharmaceutical companies, clinicians and academia, supports open-access drug discovery around the world. And it’s bringing hope to the 300 million people afflicted by rare diseases and a world ravaged by COVID-19.
Submitted by kobrien on 03/28/2022
The COVID-19 pandemic sparked an urgent need for innovation in all aspects of our lives – and researchers rose to the challenge. From COVID-19 diagnostics and treatments to changes in how we work and receive healthcare, the pandemic has fast-tracked innovation across sectors.
High-potential researchers and businesses around the world did a pandemic pivot, shifting their work and resources to respond to the world’s pressing need for solutions. In Canada, Seyyedarash (Arash) Haddadi’s story is a standout example of innovation partnerships helping to counter the COVID-19 threat.
Submitted by msilvarodrigues on 02/17/2021
Across Canada, businesses and organizations grappling with the impact of COVID-19 are getting support from an unexpected resource: top local business students.
Thanks to the recently launched Business Strategy Internship (BSI) program, Mitacs helps match students from top schools with employers looking for support to manage and grow their operations in an environment disrupted by the pandemic.
Submitted by msilvarodrigues on 10/27/2020
Quebec entrepreneur and former Mitacs intern Azadeh Dastmalchi developed a medical-grade smartwatch after struggling to find a device that could help her father monitor his hypertension. Now, in addition to targeting the one in three adults suffering from high blood pressure in North America, her company VitalTracer is pivoting its solution to assist with early detection and monitoring of COVID-19 symptoms.
Submitted by msilvarodrigues on 10/16/2020
With the onset of the COVID-19 crisis, CAMufacturing Solutions Inc. knew they needed to bring their expertise in additive manufacturing, or 3D printing, to support the rising demand for quick production of personnel protective equipment (PPE) for the health care community.
Submitted by drambing on 08/12/2020
As of July 27, 2020, the number of COVID-19 confirmed cases worldwide reached 16.3 million people, with 114,000 cases in Canada. About two to eight percent of COVID-19 cases experience severe symptoms that lead to respiratory distress, organ failure, and even death. Currently, regular medical checkups consist of one-on-one phone calls to monitor the patient’s vital signs remotely.
Submitted by drambing on 06/26/2020
When Gurudeeban Selvaraj and Satyavani Kaliamurthi came to Canada in 2019, they had no idea they would be creating both a preventative vaccine and a curing drug to address the millennium’s biggest pandemic.
Submitted by drambing on 04/21/2020
When the COVID-19 pandemic was announced and the Government of Canada called upon researchers and businesses to develop solutions, Ramtin Rasoulinezhad answered.
A graduate student at Western University, Ramtin was working as a research engineer supported by Mitacs Accelerate . He was working on the Net Zero Energy Building project with AVL Manufacturing when CEO Vince Discristofaro selected him to work directly with the Hybrid Solution Division.
Submitted by drambing on 04/08/2020
With the spread of COVID-19, a leading University of Alberta research team has developed an innovative coating capable of killing viruses.